Inhibitors of dipeptidyl peptidase iv induce secretion of transforming growth factor-β1 in PWM-stimulated PBMC and T cells

Immunology

Volumn 91, Issue 3, 1997, Pages 354-360

  Reinhold, D ^a   Bank, U ^a   Buhling F ^a   Lendeckel, U ^a   Faust, J ^b   Neubert, K ^b   Ansorge, S ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHICKEN; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INHIBITION KINETICS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030744259     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.d01-2258.x     Document Type: Article

References (30)

1. FLEISCHER B. (1994) CD26: a surface protease involved in T-cell activation. J Immunol 15, 180.
2. YARON A. & NAIDER F. (1993) Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28, 31.
3. MATTERN T., FLAD H.-D., FELLER A.C., HEYMANN E. & ULMER A.J. (1989) Anti-DPP-IV and anti-Tal but not IOT 15 should be clustered in CDw26. In: Leukocyte Typing IV (eds. W. Knapp, B. Dörken, W. R. Gilks et al.), p. 416. Oxford University Press, Oxford, New York, Tokyo.
4. SCHÖN E., DEMUTH U.H., BARTH A. & ANSORGE S. (1984) Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylprolin in T-lymphocytes. Biochem J 223, 255.
5. SCHÖN E., EICHMANN E., GRUNOW R. et al. (1986) Dipeptidyl peptidase IV in human T lymphocytes. An approach to the role of a membrane peptidase in the immune system. Biomed Biochem Acta 45, 1523.
6. BÜHLING F., KUNZ D., REINHOLD D. et al. (1994) Expression and functional role of dipeptidyl peptidase IV on human natural killer cells. Nat Immun 13, 270.
7. BÜHLING F., JUNKER U., REINHOLD D., NEUBERT K., JÄGER L. & ANSORGE S. (1995) Functional role of CD26 on human B lymphocytes. Immunol Lett 45, 47.
8. DANG N.H., TORIMOTO Y., DEUSCH K., SCHLOSSMAN S.F. & MORIMOTO C. (1990) Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 Tcell activation via CD3 and CD2 pathways. J Immunol 144, 4092.
9. DANG N.H., TORIMOTO Y., SUGITA K. et al. (1990) Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol 145, 3963.
10. MORIMOTO C., TORIMOTO Y., LEVINSON G. et al. (1989) 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol 143, 3430.
11. MITTRÜCKER H.W., STEEG C., MALISSEN B. & FLEISCHER B. (1995) The cytoplasmic tail of the T cell receptor zeta-chain is requirend for signaling via CD26. Eur J Immunol 25, 295.
12. SCHÖN E., DEMUTH H.-U., EICHMANN E. et al. (1989) Dipeptidyl peptidase IV in human T lymphocytes Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand J Immunol 29, 127.
13. PLANA M., VINAS O., DELA CALLE-MARTIN O. et al. (1991) Induction of interleukin 2 and interferon-gamma and enhancement of IL-2 receptor expression by a CD26 monoclonal antibody. Eur J Immunol 21, 1085.
14. REINHOLD D., BANK U., BÜHLING F. et al. (1993) Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against Dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells and IL-2 and IL-6 production. Immunobiology 188, 403.
15. REINHOLD D., BANK U., BÜHLING F. et al. (1994) Inhibitors of Dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiology 192, 121.
16. FLAD H.-D., GRUBER M., SCHOLZ W., FELLER A.C., ULMER A.J. & HEYMANN E. (1992) Phenotypic and functional characterization of human T lymphocytes defiened by monoclonal antibody against dipeptidyl peptidase IV (DP IV). Adv Biosci 65, 19.
17. TANAKA T., KAMEOKA J., YARON A., SCHLOSSMAN F.S. & MORIMOTO C. (1993) The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90, 4586.
18. BOYUM A. (1968) Separation of leukocytes from blood and bone marrow. IV. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 97, 77.
19. SCHÖN E., BORN I., DEMUTH H.-U. et al. (1991) Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol Chem Hoppe Seyler 372, 305.
20. REINHOLD D., BANK U., BÜHLING F. et al. (1994) Transforming growth factor-β1 (TGF-β1) inhibits DNA synthesis of PWM stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokines 6, 382.
21. 1. J Immunol Methods 158, 17.
22. KEKOW J., WACHSMAN W., MCCUTCHAN J.A. et al. (1991) Transforming growth factor-β and suppression of humoral immune responses in HIV infection. J Clin Invest 87, 1010.
23. MASSAGUE J. (1984) Type beta transforming growth factor from feline sarcoma virus-transformed rat cells. Isolation and biological properties. J Biol Chem 259, 9756.
24. REINHOLD D., BANK U., BÜHLING F., LENDECKEL U. & ANSORGE S. (1995) Transforming Growth Factor beta1 inhibits Interleukin-10 mRNA expression and production in pokeweed mitogen-stimulated peripheral blood mononuclear cells and T cells. J Interferon Cytokine Res 15, 685.
25. WAHL S.M., HUNT D.A., WONG H.L. et al. (1988) Transforming growth factor-b is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 140, 3026.
26. ESPEVIK T., WAAGE A., FAXVAAG A. & SHALABY M.R. (1990) Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1beta and transforming growth factor-beta. Cell Immunol 126, 47.
27. ESPEVIK T., FIGARI I.S., RANGES G.E. & PALLADINO M.A. (1988) Transforming growth factor-β1 (TGF-β1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-drived TGF-β1 and TGF-β2. and recombinant human TGF-β1. J Immunol 140, 2312.
28. ANSORGE S., SCHÖN E. & KUNZ D. (1991) Membrane-bound peptidases of lymphocytes: Functional implications. Biomed Biochem Acta 50, 799.
29. HOFFMANN T., FAUST J., NEUBERT K. & ANSORGE S. (1993) Dipeptidyl peptidase IV (CD26) and aminopeptidase N (CD13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett 336, 61.
30. ZHOU D., MUNSTFR A. & WINCHURCH R.A. (1991) Pathologic-concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-β. FASEB J 5, 2582.